Shilpa Pharma, Inc.

Shilpa Pharma, Inc. is the US operating company of Shilpa Medicare Limited, one of the largest specialty generic pharmaceutical companies in the world. Based in India, they have API and finished formulation production facilities while providing high-quality, affordable medicines trusted by healthcare professionals and patients in over 100 countries globally. Shilpa Medicare Limited is establishing collaborations including in/out-licensing of products and technologies, strategic alliances, joint ventures, and mergers and acquisitions as they strengthen their presence in other markets across the world. Shilpa Pharma, Inc. will develop and support these collaborations here in the US. To learn more, please visit vbshilpa.com.

Phylloceuticals

Phylloceuticals will revolutionize the production of medicine using the simplest of plants. A unique technology company perfectly positioned to bring therapeutics to market for patients, healthcare systems, and our nation’s national security needs, Phylloceuticals accomplishes this with the highest level of attention to speed, cost and safety. Phylloceutical's technology is a reduced-risk, clean-profile solution, and is leading the way for pharmaceutical firms to meet higher standard for social impact. All while broadening access to critical therapeutics for underserved areas and people.

Plexus Ventures LLC

Plexus Ventures is a prominent healthcare advisory boutique. Our team of professionals are located in markets all over the world – the United States, Europe, and the Asia-Pacific market, including China and Japan – enabling us to combine local knowledge with global reach.

Remeaid Pharmaceuticals Company Limited

Innovative and effective medicines and products that improve total health and promote self-care.

ELRIG UK

The European Laboratory Research and Innovation Group UK (ELRIG) is a not for profit company whose purpose is to bring the life science and drug discovery communities together to learn, share, connect, innovate and collaborate. We achieve this through the provision of world class conferences, networking events, webinars and digital content. Our values are to always ensure the highest quality of content and that content will be made readily accessible to all, and that we will always be an inclusive organisation, serving a diverse scientific community. In addition, ELRIG will always be a volunteer led organisation, run by the life sciences community, for the life sciences community, on a not for profit basis. ELRIG has evolved from the Laboratory Robotics Interest Groups set up in North America in the early 2000’s, and has become an independent commercial enterprise, with no major benefactors nor significant funding from a single source. Instead ELRIG depends on key partners to provide rent-free venues and the vendor community to purchase sponsorship opportunities at its events. ELRIG is unique in that it considers vendors to be very much part of the life science community and incorporates presentations on their innovations into its podium programming. Led by a board of volunteers, and run by a small team of employees, ELRIG successfully hosts at least 5 conferences and 5 networking events per year, which bring together world class speakers, that present the latest research and innovation from their laboratories. Events vary in size from 40 attendees at our tier 2 events (primarily networking or webinars), to 300 plus attendees at our tier 1 events (primarily 1 to 2 day conferences), to greater than 1500 attendees at our flag ship Drug Discovery meeting. All these events are run as free-to-attend, with speaker expenses and delegate subsistence paid for by ELRIG, which is only possible due to the support of its sponsors.